United States · FDA National Drug Code directory
DAPSONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-551_1a5c37bb-155e-4a03-afc6-4a4ef1f9dce1
- Product NDC
- 46708-551
- Form
- GEL
- Composition / generic term
- DAPSONE
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260701
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPSONE — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (46708-551-30) / 30 g in 1 TUBE · 46708-551-30
- 1 TUBE in 1 CARTON (46708-551-60) / 60 g in 1 TUBE · 46708-551-60
- 1 TUBE in 1 CARTON (46708-551-90) / 90 g in 1 TUBE · 46708-551-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →